ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data

July 30, 2010

Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures

March 4, 1994

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009

DCPC Board Ok’s Grant Programs In Prevention, Public Education

October 30, 1992

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002